ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

Walter P. Maksymowych, MB ChB, FACP, FRCP(C)  |  December 1, 2022

PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting ReportsPsoriatic Arthritis Tagged with:ACR Convergence 2022ACR Convergence 2022 – PsApsoriatic arthritis

New ARP President Kori Dewing, ARNP, DNP, Traces Her Journey to This Point & Possibilities Moving Forward

Leslie Mertz, PhD  |  November 29, 2022

Kori Dewing, ARNP, DNP, has been working in healthcare since high school. As she begins her term as president of the ARP, she is building on nearly two decades of volunteer experience with the ARP and ACR to continue supporting rheumatology professionals and advancing the College’s values of inclusion, collaboration and community.

Filed under:Interprofessional PerspectiveProfiles Tagged with:ARP presidentKori Dewing

Advocacy Involvement ‘An Antidote to Burnout,’ Says New Government Affairs Chair Christina Downey, MD

Gretchen Henkel  |  November 29, 2022

The new chair of the ACR’s Government Affairs Committee, Dr. Downey says physicians play a vital role in helping policymakers understand how policies and laws affect patients and the practice of rheumatology.

Filed under:Legislation & AdvocacyProfiles Tagged with:AdvocacyburnoutChristina DowneyGovernment Affairs Committee (GAC)

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

Ashley Krivohlavek  |  November 29, 2022

PHILADELPHIA—“At age 12, I was diagnosed with psoriasis (PsO), followed by a diagnosis of psoriatic arthritis (PsA) at age 30,” said Ashley Krivohlavek of Oklahoma City in a poster presentation at ACR Convergence 2022. “I’m now 38.”   Ms. Krivohlavek’s Story In 2020, I had been on an infused biologic for 18 months, but my…

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsMeeting ReportsOpinionPatient PerspectivePsoriatic ArthritisSpeak Out Rheum Tagged with:ACR Convergence 2022ACR Convergence 2022 – PsApatient perspectivespsoriatic arthritis

Is Gout an Autoinflammatory Syndrome After All?

Jason Liebowitz, MD, FACR  |  November 29, 2022

PHILADELPHIA—The term autoinflammatory syndrome was coined by Daniel L. Kastner, MD, PhD, National Institutes of Health (NIH), Bethesda, Md., not long after he discovered that mutations in the gene MEFV, which codes for the protein pyrin, are responsible for familial Mediterranean fever (FMF).1 Early on, the term was meant to signify monogenic conditions in which…

Filed under:ACR ConvergenceConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:ACR Convergence 2022ACR Convergence 2022 – GoutGout

Gout Research at a Glance

Lisa Stamp, MBChB, FRACP, PhD  |  November 28, 2022

PHILADELPHIA—Approximately 60 research abstracts on gout were accepted for presentation at ACR Convergence 2022, including two plenary abstract presentations. It is exciting to see a wealth of research on gout being undertaken worldwide. Here, we highlight important points from seven of these studies. 1. Abstract 1810: Frequency and Patterns of Opioid Use in the Management…

Filed under:ConditionsGout and Crystalline ArthritisMeeting ReportsResearch Rheum Tagged with:ACR Convergence 2022ACR Convergence 2022 – Gout

Themes of Drama, Heroism & New Challenges Threaded President’s & Keynote Addresses at ACR Convergence 2022

Thomas R. Collins  |  November 18, 2022

PHILADELPHIA—Abraham Verghese, MD, best-selling author and infectious disease specialist, told a packed hall at the opening ceremony of ACR Convergence that he didn’t need to look far to find heroes not much different from the protagonists he has written about in his novels, which blend medical mystery with the passions and tragedies of human existence….

Filed under:Meeting Reports Tagged with:ACR Convergence 2022

ACR Scores Wins for Rheumatology Community at AMA House of Delegates Interim Meeting

From the College  |  November 17, 2022

Key successes for the rheumatology community secured by the ACR’s delegation include passage of the ACR’s resolution addressing pharmacy benefit administrators, advances in policies to protect rheumatologists and patients in the post-Dobbs landscape and retention of the rheumatology’s representation in the AMA House of Delegates.

Filed under:Legislation & Advocacy Tagged with:ACR advocacyAMA House of Delegates (HOD)third-party pharmacy benefit administrators

A New President Takes the ACR Helm: Introducing Douglas White, MD, PhD

Leslie Mertz, PhD  |  November 17, 2022

In his new role as the 86th president of the ACR, Douglas White, MD, PhD, is excited about the opportunities to serve and energize the organization and members in the coming year.

Filed under:American College of RheumatologyPresident's PerspectiveProfiles Tagged with:ACR presidentDr. Douglas White

Case Report: Lupus Nephritis or a Mimic?

Matthew J. Mandell, DO, Yishui Chen, MD, Prerna Rastogi, MD, PhD, & Rebecca Tuetken, MD, PhD  |  November 10, 2022

Syphilis, an ancient disease caused by the spirochete Treponema pallidum, has been historically referred to as the great mimicker given its heterogenous presentation. Both systemic lupus erythematosus (SLE) and syphilis can have multi-systemic involve­ment. Both parvovirus B19 and syphilis have been reported to cause histologic features similar to those seen in lupus nephritis.  We present…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportFellowsFellows ForumFellows-in-TrainingLupus nephritisparvovirus B19syphilis

  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 337
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences